Skip to main content

Adapthealth Corp (AHCO) Stock

Adapthealth Corp Stock Details, Movements and Public Alerts

Stock Details

Adapthealth Corp (AHCO), a prominent company in the healthcare sector within the medical devices industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $10.40. Over the past 52 weeks, it has ranged between $7.11 and $11.63. This places the current price at 89.4% of its 52-week high and 46.3% above its 52-week low. Recent trading volume was recorded at 819,200. The 14-day Relative Strength Index (RSI) stands at 64.21, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $9.38 by 10.87%. Similarly, it is above its 200-day moving average of $9.28 by 12.07%. The MACD histogram is 0.07, indicating bullish momentum (MACD Line: 0.14, Signal Line: 0.07). There is currently 1 active alert set for AHCO by users.

52-Week Range

$11.63 - $7.11

-10.58% from high · +46.27% from low

Avg Daily Volume

1,046,372

20-day average

100-day avg: 1,041,884

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

17.56

Near market average

Forward P/E

8.30

Earnings expected to grow

Price to Book

0.81

EV/EBITDA

4.90

EPS (TTM)

$0.55

Price to Sales

0.40

Beta

1.78

More volatile than market

How is AHCO valued relative to its earnings and growth?
Adapthealth Corp trades at a P/E ratio of 17.56, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 8.30 is lower than the current P/E, indicating analysts expect earnings to grow over the next year.
What is AHCO's risk profile compared to the market?
With a beta of 1.78, Adapthealth Corp is significantly more volatile than the market. For every 10% market move, this stock tends to move 18% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 0.81 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

2.53%

Operating Margin

8.18%

EBITDA

$632.45M

Return on Equity

5.52%

Return on Assets

3.64%

Revenue Growth (YoY)

1.80%

Earnings Growth (YoY)

6.70%

How profitable and efficient is AHCO's business model?
Adapthealth Corp achieves a profit margin of 2.53%, meaning it retains $2.53 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 8.18% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 5.52% and ROA at 3.64%, the company achieves moderate returns on invested capital.
What are AHCO's recent growth trends?
Adapthealth Corp's revenue grew by 1.80% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 6.70% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against MEDICAL DEVICES industry averages for proper context.

Company Size & Market

Market Cap

$1.3B

Revenue (TTM)

$3.26B

Revenue/Share (TTM)

$24.12

Shares Outstanding

135.42M

Book Value/Share

$12.20

Asset Type

Common Stock

What is AHCO's market capitalization and position?
Adapthealth Corp has a market capitalization of $1.3B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 135.42M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DEVICES industry, it competes with other firms in this sector.
How does AHCO's price compare to its book value?
Adapthealth Corp's book value per share is $12.20, while the current stock price is $10.40, resulting in a price-to-book (P/B) ratio of 0.85. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$13.25

27.40% upside potential

Analyst Recommendations

Strong Buy

1

Buy

6

Hold

1

Sell

0

Strong Sell

0

How reliable are analyst predictions for AHCO?
8 analysts cover AHCO with 88% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $13.25 implies 27.4% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on AHCO?
Current analyst recommendations:1 Strong Buy, 6 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 1, 2025, 02:13 AM

Technical Indicators

RSI (14-day)

64.21

Neutral

50-Day Moving Average

$9.38

10.87% above MA-50

200-Day Moving Average

$9.28

12.07% above MA-200

MACD Line

0.14

MACD Signal

0.07

MACD Histogram

0.07

Bullish

What does AHCO's RSI value tell investors?
The RSI (Relative Strength Index) for AHCO is currently 64.21, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret AHCO's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.14 above the signal line at 0.07, with histogram at 0.07. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($9.38) is above the 200-day MA ($9.28), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 12, 2025, 12:45 AM

Active Alerts

Alert Condition
Price increases by
Threshold
40%
Created
Nov 19, 2025, 01:27 AM

Stay Ahead of the Market with Adapthealth Corp Alerts

Set up price alerts for Adapthealth Corp and get notified instantly when the price hits your target. Never miss an important price movement again.